Eisenmenger syndrome is a serious, irreversible complication of certain congenital heart defects. It develops when a hole or abnormal connection in the heart, present since birth, eventually causes permanent damage to the blood vessels in the lungs. Over time, this damage reverses the direction of blood flow through the defect, sending oxygen-poor blood out to the body and causing a bluish discoloration of the skin known as cyanosis.
Not everyone born with a heart defect develops Eisenmenger syndrome. It occurs only when a significant defect goes unrepaired long enough for the lungs’ blood vessels to sustain lasting damage. Understanding how the syndrome progresses, what it feels like, and how it’s managed can help you or a loved one navigate what is a complex, lifelong condition.
How the Syndrome Develops
A normal heart keeps oxygen-rich blood (on the left side) completely separate from oxygen-poor blood (on the right side). When a baby is born with a large hole between the heart’s chambers or an abnormal connection between major blood vessels, blood is pushed from the higher-pressure left side into the lower-pressure right side. This is called a left-to-right shunt. The result is that too much blood floods into the lungs.
For years or even decades, the lungs cope with this extra flow. But the constant overload gradually damages the small arteries in the lungs through three cascading processes. First, the blood vessels tighten in response to the excess pressure. Then the muscular walls of those vessels thicken and stiffen permanently, a process called vascular remodeling. Finally, blood clots begin forming inside the narrowed vessels, further increasing resistance. Eventually the pressure in the lungs climbs so high that it exceeds the pressure on the left side of the heart, and the shunt reverses direction. Now oxygen-poor blood flows from right to left, bypassing the lungs and entering the general circulation. That reversal is the defining moment of Eisenmenger syndrome.
Which Heart Defects Lead to It
The most common underlying defects are large holes between the heart’s lower chambers (ventricular septal defects), holes between the upper chambers (atrial septal defects), and a persistent connection between the aorta and pulmonary artery (patent ductus arteriosus). More complex defects, such as a combination of abnormalities seen in conditions like atrioventricular canal defects, can also lead to Eisenmenger syndrome. The key factor is the size of the defect: small holes that produce little extra flow rarely cause lung vessel damage severe enough to reverse the shunt. Large, unrepaired defects carry the highest risk.
Signs and Symptoms
In the early years, while blood is still flowing left to right, a person may have few noticeable symptoms. As the shunt begins to reverse, symptoms emerge and tend to worsen over time. The hallmark sign is cyanosis, a bluish tint to the lips, fingertips, and skin caused by low oxygen levels in the blood. Many people also develop digital clubbing, where the fingertips and toes become rounded and bulging at the nails.
Shortness of breath during physical activity is usually the symptom that brings people to a doctor. Other common complaints include fatigue, dizziness, fainting spells, chest pain, and heart palpitations. Because the body senses chronic low oxygen, it ramps up production of red blood cells. This thickens the blood (a condition called secondary erythrocytosis), which can cause headaches, blurred vision, and an increased risk of blood clots and stroke. Some people experience coughing up blood as damaged lung vessels become fragile.
How It’s Diagnosed
Doctors usually suspect Eisenmenger syndrome when a known congenital heart defect is accompanied by cyanosis and signs of high lung pressure. An echocardiogram (ultrasound of the heart) is the first-line tool, using Doppler measurements to estimate pressures inside the heart and lungs and to visualize the direction of blood flow through the defect.
A definitive diagnosis typically requires cardiac catheterization, a procedure where a thin tube is threaded into the heart to directly measure pressures and calculate how resistant the lung vessels have become. In one study, diastolic pulmonary artery pressures of at least 45 mmHg were associated with disease progression. Critically, during catheterization doctors test whether the high lung pressure responds to vasodilators. If the resistance doesn’t drop, the damage is considered irreversible, and surgical repair of the original defect is no longer an option because closing the hole would leave the right side of the heart straining against an immovable wall of pressure.
Treatment Options
There is no cure for Eisenmenger syndrome short of transplantation, but several therapies can ease symptoms and slow progression. Treatment focuses on lowering the pressure in the lung vessels without dangerously dropping blood pressure in the rest of the body.
Two main classes of medication are used. The first works by blocking a protein called endothelin that narrows blood vessels. Bosentan, the most studied drug in this class for Eisenmenger patients, has been shown in controlled trials to improve exercise capacity and heart function without worsening blood oxygen levels. The second class relaxes lung blood vessels by boosting the effect of nitric oxide, a natural chemical that widens arteries. Drugs in this group, such as sildenafil and tadalafil, act preferentially on the lungs rather than the whole body, which is important because a drop in body-wide blood pressure could worsen the right-to-left shunt and further lower oxygen levels.
European cardiology guidelines from 2020 recommend a proactive approach to treatment, including combination therapy and, in some cases, continuous infusion of a third class of drugs called prostacyclins, which further widen the pulmonary arteries.
Supportive Care
Beyond medication, everyday management matters. Supplemental oxygen at home can help some people feel less short of breath, though it doesn’t reverse the underlying problem. Careful monitoring of red blood cell levels is essential. While the body’s overproduction of red blood cells is a compensatory response to low oxygen, extremely high levels can cause dangerous thickening of the blood. In symptomatic cases, a procedure to remove a controlled amount of blood (phlebotomy) may be performed, but it’s done cautiously because removing too many red blood cells worsens oxygen delivery. Iron supplementation is often needed alongside to prevent iron-deficient red blood cells, which are stiffer and circulate less effectively.
Transplantation
For patients whose symptoms continue to worsen despite medication, heart-lung or lung transplantation (with simultaneous repair of the heart defect) is the only remaining option. Transplantation is typically reserved for people who are severely limited in daily life, because the overall survival of stable, medically managed patients has historically been comparable to post-transplant survival.
In a study of 63 Eisenmenger patients transplanted between 1985 and 2012, the 30-day mortality was 11%. Those who survived the first month had a one-year survival rate of about 84% and a median post-transplant survival of 12 years. For patients who made it through the first year, the outlook improved further, with a median survival of nearly 15 years. The leading causes of late death were infection and chronic rejection of the transplanted lungs. Deciding when to list for transplant remains one of the most difficult clinical judgments in this field, as reliable risk-scoring tools for Eisenmenger patients are still evolving.
Long-Term Outlook
Eisenmenger syndrome is a lifelong condition with a shortened life expectancy, though many people live well into middle age. In a large cohort analysis, survival at ages 30, 40, 50, and 60 was 96%, 87%, 67%, and 49%, respectively. From the point of diagnosis, about 73% of patients survived three years and roughly half survived nine years. Importantly, these survival figures are similar to those seen in other forms of severe pulmonary hypertension, challenging an older belief that Eisenmenger patients have a uniquely better prognosis.
Certain situations carry elevated risk. Pregnancy is considered extremely dangerous: maternal mortality ranges from 30% to 50%, with some reports citing rates as high as 65% when delivery is by cesarean section. Fetal outcomes are also poor, with only about 15% of infants delivered at full term in one series, and fetal loss around 7% to 8%. For these reasons, pregnancy is strongly discouraged in women with Eisenmenger syndrome.
Other high-risk scenarios include dehydration (which thickens already viscous blood), general anesthesia (which can shift the shunt balance), high-altitude travel, and strenuous exercise. People with Eisenmenger syndrome generally learn to pace their activity around their oxygen reserves and to avoid situations that could trigger a sudden drop in blood pressure or oxygen levels.